Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Jul;105(1):120–124. doi: 10.1046/j.1365-2249.1996.d01-724.x

Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type

J SOBAJIMA 1, S OZAKI 1, T OKAZAKI 1, F OSAKADA 1, S SUMITA 1, K MORI 1, K NAKAO 1
PMCID: PMC2200488  PMID: 8697619

Abstract

We analysed the clinical significance of ANCA in patients with ulcerative colitis. On either an indirect immunofluorescence assay or an ELISA with fixed neutrophils, 71% (25/35) of the patients were positive for ANCA. However, only half of them reacted with either cathepsin G or lactoferrin. Western blot assays revealed positive bands in 40% (10/25) of the antibody-positive patients. The sizes of the bands detected were ≈58, 47, 44, 40, and 28 kD. No significant correlation was found between the ANCA positivity and various variables, i.e. disease activity, extent of lesion, or treatment of the disease. The anti-cathepsin G and 28-kD positivity, however, significantly correlated with a refractory type of ulcerative colitis.

Keywords: anti-neutrophil cytoplasmic antibodies, ulcerative colitis, cathepsin G, 28-kD antigen

Full Text

The Full Text of this article is available as a PDF (248.8 KB).


Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES